- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Judgment of the Court of First Instance (Seventh Chamber) of 23 September 2009. # GlaxoSmithkline SpA and Others v Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM). # Community trade mark - Invalidity proceedings - Community word mark FAMOXIN - Earlier national word marks LANOXIN - Relative ground for refusal - No likelihood of confusion - Article 8(1)(b) and Article 52(1)(a) of Regulation (EC) No 40/94 (now Article 8(1)(b) and Article 53(1)(a) of Regulation (EC) No 207/2009) - Proof of use - Article 56(2) and (3) of Regulation No 40/94 (now Article 57(2) and (3) of Regulation No 207/2009). # Cases T-493/07, T-26/08 and T-27/08.
ECLI:EU:T:2009:355
62007TJ0493
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
(Cases T-493/07, T-26/08 and T-27/08)
Community trade mark – Invalidity proceedings – Community word mark FAMOXIN – Earlier national word marks LANOXIN – Relative ground for refusal – No likelihood of confusion – Article 8(1)(b) and Article 52(1)(a) of Regulation (EC) No 40/94 (now Article 8(1)(b) and Article 53(1)(a) of Regulation (EC) No 207/2009) – Proof of use – Article 56(2) and (3) of Regulation No 40/94 (now Article 57(2) and (3) of Regulation No 207/2009)
Community trade mark – Surrender, revocation and invalidity – Relative grounds of invalidity – Registration contrary to Article 8(1)(b) of Regulation No 40/94 (Council Regulation No 40/94, Art. 52(1)(a)) (see paras 50-57, 73-76)
Re:
Three actions brought against the decisions of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 14 September 2007 (Case R 8/2007-1), 20 November 2007 (Case R 10/2007-1) and 19 November 2007 (Case R 9/2007-1), relating to cancellation proceedings between, on the one hand, GlaxoSmithkline SpA, Laboratórios Wellcome De Portugal Lda and The Wellcome Foundation Ltd, and, on the other, Serono Genetics Institute SA.
Information relating to the case
Registered Community trade mark subject of the application for a declaration of invalidity:
Community word mark FAMOXIN for goods and services in Class 5 – Application No 2491298
Proprietor of the Community trade mark:
Serono Genetics Institute SA
Party requesting the declaration of invalidity of the Community trade mark:
GlaxoSmithkline SpA ; Laboratórios Wellcome de Portugal, Lda ; and The Wellcome Foundation Ltd
Trade mark right of the party requesting the declaration of invalidity:
National word mark LANOXIN for goods in Class 5
Decision of the Cancellation Division:
Applications dismissed
Decision of the Board of Appeal:
Appeals dismissed
Operative part
The Court:
1.Joins Cases T-493/07, T-26/08 and T-27/08 for the purposes of the present judgment;
2.Dismisses the actions;
3.Orders GlaxoSmithKline SpA, Laboratórios Wellcome de Portugal, Lda and The Wellcome Foundation Ltd to pay the costs.